JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hooks, M. S.
Right arrow Articles by Kalivas, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hooks, M. S.
Right arrow Articles by Kalivas, P. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DOPAMINE

Involvement of dopamine and excitatory amino acid transmission in novelty-induced motor activity

MS Hooks and PW Kalivas

Alcohol and Drug Abuse Program, Washington State University, Pullman.

The increase in locomotor activity expressed by rats in a novel environment demonstrates individual variability, and the present study evaluated an hypothesis that the variability resides, in part, in differences in neurotransmission in the nucleus accumbens, ventral tegmental area or ventral pallidum. Rats were divided into equal groups expressing either a high or low response in a novel open field. Subsequently, dopamine, the excitatory amino acid agonist alpha-amino-3- hydroxy-5-methylisoxazole-4-propionic acid (AMPA) or the mu opioid agonist [D-Ala2, MePhe4, Gly-ol5] enkephalin (DAMGO) was microinjected into one of the three brain nuclei, and motor activity was monitored. All three drugs produced a dose-dependent elevation in motor activity in all three brain nuclei. However, the motor response elicited by dopamine in the ventral pallidum and nucleus accumbens was significantly greater in the rats demonstrating a high locomotor response to novelty. Similarly, the motor response elicited by AMPA in the ventral pallidum, nucleus accumbens or ventral tegmental area was enhanced in the high versus low responding rats. In contrast, at no dose and in no brain nucleus was the motor response to DAMGO different between high and low responding rats. These data indicate that alterations in dopamine and excitatory amino acid but not enkephalin neurotransmission in the ventral pallidum, nucleus accumbens and ventral tegmental area are associated with differences in motor activity expressed by animals in a novel environment.

Volume 269, Issue 3, pp. 976-988, 06/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Pharmacol. Rev.Home page
J. Fichna, A. Janecka, J. Costentin, and J.-C. Do Rego
The Endomorphin System and Its Evolving Neurophysiological Role
Pharmacol. Rev., March 1, 2007; 59(1): 88 - 123.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. C. Dulawa, D. K. Grandy, M. J. Low, M. P. Paulus, and M. A. Geyer
Dopamine D4 Receptor-Knock-Out Mice Exhibit Reduced Exploration of Novel Stimuli
J. Neurosci., November 1, 1999; 19(21): 9550 - 9556.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
L. Churchill, M. A. Klitenick, and P. W. Kalivas
Dopamine Depletion Reorganizes Projections from the Nucleus Accumbens and Ventral Pallidum That Mediate Opioid-Induced Motor Activity
J. Neurosci., October 1, 1998; 18(19): 8074 - 8085.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics.